- Home
- KTOS vs BDTX Comparison
KTOS vs BDTX Comparison
Compare KTOS & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KTOS | BDTX |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 220.3M |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KTOS | BDTX |
|---|---|---|
| Price | $75.45 | $2.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $84.00 | $10.60 |
| AVG Volume (30 Days) | ★ 2.1M | 1.7M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.23 | N/A |
| EPS | 0.13 | ★ 0.38 |
| Revenue | ★ $1,284,800,000.00 | $70,000,000.00 |
| Revenue This Year | $19.25 | N/A |
| Revenue Next Year | $20.15 | N/A |
| P/E Ratio | $636.45 | ★ $6.72 |
| Revenue Growth | ★ 14.00 | N/A |
| 52 Week Low | $23.90 | $1.20 |
| 52 Week High | $112.57 | $4.94 |
Technical Indicators
Market Signals| Indicator | KTOS | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 27.63 |
| Support Level | $69.31 | $2.61 |
| Resistance Level | $79.47 | $2.72 |
| Average True Range (ATR) | 3.89 | 0.25 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 56.52 | 18.30 |
Price Performance
Historical ComparisonAbout KTOS Kratos Defense & Security Solutions Inc.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.